Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A B Fischmann

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Cancer Treatment Reports|April 1, 1979
Exposure to chemicals, physical agents, and biologic agents in mycosis fungoides and the Sézary syndromeA B Fischmann, P A Bunn, J G Guccion, et al.
Cancer Treatment Reports|April 1, 1979
Preliminary evaluation of 15 chemotherapeutic agents applied topically in the treatment of mycosis fungoidesC L Argyropoulos, S I Lamberg, W E Clendenning, et al.
Gastroenterology|July 1, 1977
Gastrointestinal involvement in the Sézary syndromeM I Cohen, L W Widerlite, G P Schechter, et al.
Cancer|August 1, 1979
Necrolytic migratory erythema, presenting as candidiasis, due to a pancreatic glucagonomaR Katz, A B Fischmann, J Galotto, et al.
Cancer Treatment Reports|April 1, 1979
Blood and lymph node T lymphocytes in cutaneous T cell lymphoma: evaluation by light microscopyG P Schechter, P A Bunn, A B Fischmann, et al.
Blood|March 1, 1987
Evaluation of circulating malignant cells provides prognostic information in cutaneous T cell lymphomaG P Schechter, E A Sausville, A B Fischmann, et al.
Human Pathology|November 1, 1985
Histologic assessment of lymph nodes in mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma): clinical correlations and prognostic import of a new classification systemE A Sausville, G F Worsham, M J Matthews, et al.
Annals of Internal Medicine|September 1, 1988
Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groupsE A Sausville, J L Eddy, R W Makuch, et al.
Blood|June 25, 1992
Prognostic implications of evaluation for lymph node involvement by T-cell antigen receptor gene rearrangement in mycosis fungoidesJ W Lynch, I Linoilla, E A Sausville, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndromeF M Foss, D C Ihde, D L Breneman, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cancer Treatment Reports|April 1, 1979
Exposure to chemicals, physical agents, and biologic agents in mycosis fungoides and the Sézary syndromeA B Fischmann, P A Bunn, J G Guccion, et al.
Cancer Treatment Reports|April 1, 1979
Preliminary evaluation of 15 chemotherapeutic agents applied topically in the treatment of mycosis fungoidesC L Argyropoulos, S I Lamberg, W E Clendenning, et al.
Gastroenterology|July 1, 1977
Gastrointestinal involvement in the Sézary syndromeM I Cohen, L W Widerlite, G P Schechter, et al.
Cancer|August 1, 1979
Necrolytic migratory erythema, presenting as candidiasis, due to a pancreatic glucagonomaR Katz, A B Fischmann, J Galotto, et al.
Cancer Treatment Reports|April 1, 1979
Blood and lymph node T lymphocytes in cutaneous T cell lymphoma: evaluation by light microscopyG P Schechter, P A Bunn, A B Fischmann, et al.
Blood|March 1, 1987
Evaluation of circulating malignant cells provides prognostic information in cutaneous T cell lymphomaG P Schechter, E A Sausville, A B Fischmann, et al.
Human Pathology|November 1, 1985
Histologic assessment of lymph nodes in mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma): clinical correlations and prognostic import of a new classification systemE A Sausville, G F Worsham, M J Matthews, et al.
Annals of Internal Medicine|September 1, 1988
Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groupsE A Sausville, J L Eddy, R W Makuch, et al.
Blood|June 25, 1992
Prognostic implications of evaluation for lymph node involvement by T-cell antigen receptor gene rearrangement in mycosis fungoidesJ W Lynch, I Linoilla, E A Sausville, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndromeF M Foss, D C Ihde, D L Breneman, et al.
Pageof 2